[go: up one dir, main page]

NL2004200C2 - Use of sialyl oligosaccharides in weight management. - Google Patents

Use of sialyl oligosaccharides in weight management. Download PDF

Info

Publication number
NL2004200C2
NL2004200C2 NL2004200A NL2004200A NL2004200C2 NL 2004200 C2 NL2004200 C2 NL 2004200C2 NL 2004200 A NL2004200 A NL 2004200A NL 2004200 A NL2004200 A NL 2004200A NL 2004200 C2 NL2004200 C2 NL 2004200C2
Authority
NL
Netherlands
Prior art keywords
sialyl
bacteroides
composition
disialyllacto
sialyllacto
Prior art date
Application number
NL2004200A
Other languages
English (en)
Dutch (nl)
Inventor
Arjen Nauta
Ruprecht Jules Joost Neerven
Hermiena Christina Schoterman
Original Assignee
Friesland Brands Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friesland Brands Bv filed Critical Friesland Brands Bv
Priority to NL2004200A priority Critical patent/NL2004200C2/en
Priority to PCT/NL2011/050078 priority patent/WO2011096808A1/fr
Application granted granted Critical
Publication of NL2004200C2 publication Critical patent/NL2004200C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL2004200A 2010-02-05 2010-02-05 Use of sialyl oligosaccharides in weight management. NL2004200C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL2004200A NL2004200C2 (en) 2010-02-05 2010-02-05 Use of sialyl oligosaccharides in weight management.
PCT/NL2011/050078 WO2011096808A1 (fr) 2010-02-05 2011-02-04 Utilisation de sialyl-oligosaccharides pour gestion du poids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2004200A NL2004200C2 (en) 2010-02-05 2010-02-05 Use of sialyl oligosaccharides in weight management.
NL2004200 2010-02-05

Publications (1)

Publication Number Publication Date
NL2004200C2 true NL2004200C2 (en) 2011-08-08

Family

ID=42340788

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2004200A NL2004200C2 (en) 2010-02-05 2010-02-05 Use of sialyl oligosaccharides in weight management.

Country Status (2)

Country Link
NL (1) NL2004200C2 (fr)
WO (1) WO2011096808A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
BR112013020108A2 (pt) * 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
JP6129821B2 (ja) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された2’−フコシルラクトース、3−フコシルラクトース、およびラクトジフコテトラオースの使用
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2745705A1 (fr) * 2012-12-18 2014-06-25 Abbott Laboratories Usage nutritionnel d'oligosaccharides du lait humain
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2015003001A1 (fr) * 2013-07-01 2015-01-08 The Washington University Procédés pour identifier des compléments qui augmentent la colonisation intestinale par une espèce bactérienne isolée, et compositions dérivées
US10920283B2 (en) 2013-11-01 2021-02-16 Washington University Methods to establish and restore normal gut microbiota function of subject in need thereof
EP2885977A1 (fr) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) Composition enrichie en oligosaccharide ayant des propriétés anti-adhérence et immunomodulatrices
BR112017002627A2 (pt) 2014-08-18 2017-12-05 Nestec Sa prebióticos para reduzir o risco de obesidade no futuro
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
WO2016091265A1 (fr) 2014-12-08 2016-06-16 Glycom A/S Composition synthétique pour le traitement de troubles métaboliques
EP3065748B1 (fr) 2014-12-23 2017-11-22 4D Pharma Research Limited Une lignée de bacteroides thetaiotaomicron et son utilisation pour la réduction des inflammations
LT3193901T (lt) 2014-12-23 2018-06-11 4D Pharma Research Limited Pirino polipeptidas ir imuninė moduliacija
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS63089B1 (sr) 2015-06-15 2022-04-29 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
ES2748812T3 (es) 2015-06-15 2020-03-18 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
PT3240554T (pt) 2015-06-15 2019-11-04 4D Pharma Res Ltd Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN106389478B (zh) * 2015-07-31 2019-12-24 广州知易生物科技有限公司 脆弱拟杆菌在治疗和/或预防肥胖症或糖尿病中的应用
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
SI3209310T1 (en) 2015-11-20 2018-06-29 4D Pharma Research Limited Compositions containing bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN106852938A (zh) * 2015-12-09 2017-06-16 深圳华大基因研究院 拟杆菌(Bacteroides)在治疗和预防肥胖相关疾病中的应用
US20210205341A1 (en) * 2016-01-26 2021-07-08 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
EP3407892A1 (fr) * 2016-01-26 2018-12-05 Nestec S.A. Compositions comprenant des oligosaccharides sialylés pour utilisation chez les nourrissons ou les enfants en bas âge à des fins de prévention de l'obésité ou des comorbidités associées survenant plus tard dans la vie et pour favoriser une bonne croissance
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3520801A1 (fr) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
WO2018229236A2 (fr) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprenant des souches bactériennes
ES2841902T3 (es) 2017-06-14 2021-07-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
SG11201912105PA (en) 2017-06-14 2020-01-30 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3645025B1 (fr) 2017-06-30 2022-09-14 N.V. Nutricia Composition symbiotique de prévention de l'artériosclérose
WO2019002607A1 (fr) 2017-06-30 2019-01-03 N.V. Nutricia Composition symbiotique pour la prévention de troubles
US20220273016A1 (en) * 2019-07-18 2022-09-01 The Regents Of The University Of California Human milk oligosaccharides for control of dietary response and metabolic phenotype
WO2021191251A1 (fr) * 2020-03-25 2021-09-30 Frieslandcampina Nederland B.V. Compositions comprenant un ou plusieurs olh ayant un squelette de lacnac-lac
TW202233201A (zh) * 2020-12-16 2022-09-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 包含LNFP III和LSTa的合成組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060346A2 (fr) * 2000-02-17 2001-08-23 Wyeth Formulation nutritionnelle contenant des substances prebiotiques
WO2008076696A2 (fr) * 2006-12-18 2008-06-26 Washington University In St. Louis Microbiome intestinal en tant que biomarqueur et cible thérapeutique pour traiter l'obésité ou un trouble lié à l'obésité
WO2010002241A1 (fr) * 2008-06-30 2010-01-07 N.V. Nutricia Composition nutritive pour bébés nés par césarienne
EP2143341A1 (fr) * 2008-07-08 2010-01-13 Nestec S.A. Composition nutritionnelle contenant un mélange d'oligosaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
EP1974734A1 (fr) 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour la réduction du risque d'obésité
EP1997906A1 (fr) 2007-06-01 2008-12-03 Friesland Brands B.V. Lactobacillus
EP1997907A1 (fr) 2007-06-01 2008-12-03 Friesland Brands B.V. Bifidobactéries
NL2001377C2 (nl) 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060346A2 (fr) * 2000-02-17 2001-08-23 Wyeth Formulation nutritionnelle contenant des substances prebiotiques
WO2008076696A2 (fr) * 2006-12-18 2008-06-26 Washington University In St. Louis Microbiome intestinal en tant que biomarqueur et cible thérapeutique pour traiter l'obésité ou un trouble lié à l'obésité
WO2010002241A1 (fr) * 2008-06-30 2010-01-07 N.V. Nutricia Composition nutritive pour bébés nés par césarienne
EP2143341A1 (fr) * 2008-07-08 2010-01-13 Nestec S.A. Composition nutritionnelle contenant un mélange d'oligosaccharides

Also Published As

Publication number Publication date
WO2011096808A1 (fr) 2011-08-11

Similar Documents

Publication Publication Date Title
NL2004200C2 (en) Use of sialyl oligosaccharides in weight management.
NL2004201C2 (en) Use of sialyl oligosaccharides to modulate the immune system.
Russell et al. Metabolic activities and probiotic potential of bifidobacteria
US8591919B2 (en) Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta -1,4/1,6 linkages
ES2702631T3 (es) Composición nutricional con prebióticos y probióticos
AU2016102461A4 (en) Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
US20210330687A1 (en) Bifidogenic hypoallergenic gos compositions and methods for providing the same involving beta-galactosidase from a strain of lactobacillus delbrueckii ssp bulgaricus
TW201242518A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN103797021A (zh) 寡糖混合物以及包含该混合物的食品,特别是婴儿配方产品
TW201100537A (en) Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
JP2011504365A (ja) 乳児のための年齢に合わせた栄養システム
HUE031289T2 (hu) Fermentált bébitápszer emészthetetlen oligoszacharidokkal
Ogueke et al. Probiotics and prebiotics: Unfolding prospects for better human health
US20230270798A1 (en) Synbiotic composition
AU2014368585A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
US20210244777A1 (en) Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
CN113015440B (zh) 包含尿素和不可消化寡糖的营养组合物
WO2024227719A1 (fr) Composition nutritionnelle
WO2024227720A1 (fr) Composition nutritionnelle
RU2804305C2 (ru) Пищевая композиция, содержащая мочевину и неперевариваемые олигосахариды
WO2021255229A1 (fr) Composition nutritionnelle comprenant de l'acide 3-hydroxybutyrique pour améliorer la barrière gastro-intestinale

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee

Effective date: 20130901